Zhe Jiang Dayang Biotech Group Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 2/6
Zhe Jiang Dayang Biotech Group's earnings have been declining at an average annual rate of -9.2%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 10.3% per year. Zhe Jiang Dayang Biotech Group's return on equity is 5.9%, and it has net margins of 7%.
Anahtar bilgiler
-9.2%
Kazanç büyüme oranı
-15.6%
EPS büyüme oranı
| Chemicals Sektör Büyümesi | 12.1% |
| Gelir büyüme oranı | 10.3% |
| Özkaynak getirisi | 5.9% |
| Net Marj | 7.0% |
| Son Kazanç Güncellemesi | 30 Sep 2024 |
Gelir ve Gider Dağılımı
Zhe Jiang Dayang Biotech Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Sep 24 | 877 | 61 | 73 | 30 |
| 30 Jun 24 | 875 | 58 | 75 | 35 |
| 31 Mar 24 | 863 | 48 | 75 | 37 |
| 31 Dec 23 | 919 | 50 | 74 | 39 |
| 30 Sep 23 | 1,038 | 71 | 81 | 39 |
| 30 Jun 23 | 1,047 | 67 | 75 | 33 |
| 31 Mar 23 | 1,115 | 92 | 70 | 36 |
| 01 Jan 23 | 1,058 | 81 | 68 | 34 |
| 30 Sep 22 | 951 | 51 | 67 | 36 |
| 30 Jun 22 | 890 | 55 | 66 | 39 |
| 31 Mar 22 | 801 | 53 | 64 | 30 |
| 31 Dec 21 | 783 | 70 | 64 | 28 |
| 30 Sep 21 | 750 | 84 | 60 | 25 |
| 30 Jun 21 | 742 | 92 | 61 | 22 |
| 31 Mar 21 | 719 | 96 | 56 | 22 |
| 31 Dec 20 | 678 | 92 | 54 | 22 |
| 30 Sep 20 | 664 | 101 | 49 | 21 |
| 30 Jun 20 | 629 | 92 | 51 | 21 |
| 31 Mar 20 | 600 | 81 | 56 | 19 |
| 31 Dec 19 | 622 | 79 | 59 | 20 |
| 30 Sep 19 | 598 | 73 | 61 | 18 |
| 30 Jun 19 | 605 | 72 | 59 | 16 |
| 31 Mar 19 | 590 | 72 | 53 | 23 |
| 01 Jan 19 | 584 | 71 | 59 | 18 |
| 01 Oct 18 | 599 | 68 | 67 | 13 |
| 30 Jun 18 | 613 | 66 | 75 | 8 |
| 31 Mar 18 | 590 | 58 | 80 | 0 |
| 31 Dec 17 | 555 | 50 | 76 | 0 |
| 30 Sep 17 | 500 | 44 | 64 | 12 |
| 30 Jun 17 | 445 | 37 | 76 | 5 |
| 31 Mar 17 | 441 | 33 | 80 | 0 |
| 01 Jan 17 | 441 | 29 | 75 | 0 |
| 30 Sep 16 | 454 | 30 | 72 | 0 |
| 30 Jun 16 | 466 | 32 | 69 | 0 |
| 31 Mar 16 | 457 | 28 | 70 | 0 |
| 01 Jan 16 | 448 | 24 | 72 | 0 |
| 01 Jan 15 | 459 | 28 | 72 | 0 |
| 31 Dec 13 | 500 | 26 | 68 | 0 |
Kaliteli Kazançlar: 003017 has high quality earnings.
Büyüyen Kar Marjı: 003017's current net profit margins (7%) are higher than last year (6.8%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 003017's earnings have declined by 9.2% per year over the past 5 years.
Büyüme Hızlandırma: 003017's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Kazançlar vs. Sektör: 003017 had negative earnings growth (-13.7%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).
Özkaynak Getirisi
Yüksek ROE: 003017's Return on Equity (5.9%) is considered low.